EN
HI
Summary
As of 31 Aug, 2026, Akums Drugs & Pharmaceuticals stock price is ₹772.6. During the trading session, the stock has moved between an intraday low of ₹758.60 and an intraday high of ₹774.45. Over the last 52 weeks, Akums Drugs & Pharmaceuticals has traded between ₹409.30 and ₹783.00.
The stock has recorded a trading volume of 4,08,016 shares, with a market capitalization of ₹157393988. Its Average Traded Price (ATP) is ₹768.52, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹772.60.
Akums Drugs & Pharmaceuticals has an upper circuit limit of ₹849.85 and a lower circuit limit of ₹695.35. The total value traded stands at ₹31.36 CR, and the delivery percentage for the day is 55.89%.
The stock is currently traded with a market lot size of 1. Akums Drugs & Pharmaceuticals also offers a dividend yield of 0.39%.
Akums Drugs & Pharmaceuticals share price chart
Akums Drugs & Pharmaceuticals Share Key Metrics
Volume
4.08 L
Market Cap
12160.26 CR
LTQ@LTP
1@772.60
ATP
768.52
Var Margin
17.52 %
Circuit Range
695.35-849.85
Delivery %
55.89 %
Value
31.36 CR
ASM/GSM
No
Market Lot
1
Akums Drugs & Pharmaceuticals Fundamentals
P/E Ratio
41.68
P/B Ratio
3.56
Div. Yield
0.39
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Akums Drugs & Pharmaceuticals Resistance and Support
Pivot 766.42
Resistance
First Resistance
772.84
Second Resistance
784.47
Third Resistance
790.89
Support
First Support
754.79
Second Support
748.37
Third Support
736.74
Akums Drugs & Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 764 | 772.6 | 1.50% | 774.45 | 758.6 |
| Thu Aug 27 2026 | 769 | 761.2 | -0.64% | 778.04 | 760 |
| Wed Aug 26 2026 | 752 | 766.09 | 2.83% | 773.79 | 750 |
Akums Drugs & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-08 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals News
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Akums Drugs & Pharma announced a scheduled group investor/analyst meet on September 2, 2026. The company will participate in the Ashwamedh – Elara India Dialogue 2026 at Hyatt, Santacruz East, Mumbai.
Aug 25 2026 16:51:23
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Akums Drugs & Pharma announced the availability of the audio recording for its Investors/Analysts Conference Call, held on August 10, 2026, to discuss the un-audited financial results for Q1 FY27. The transcript will also be made available in due course.
Aug 10 2026 15:43:07
Read More
Akums Drugs & Pharmaceuticals Management
| Name | Position |
|---|---|
| Sanjeev Jain | Managing Director |
| Sandeep Jain | Managing Director |
Akums Drugs & Pharmaceuticals Similar Stocks
Jubilant Pharmova Ltd.
882.65
3.95 (0.45%)
CORONA Remedies Ltd.
2079.50
-3.70 (0.18%)
Sudeep Pharma Ltd.
1152.10
18.00 (1.59%)
Alivus Life Sciences Ltd.
1350.20
-8.00 (0.59%)
Park Medi World Ltd.
290.55
0.40 (0.14%)
Metropolis Healthcare Ltd.
588.45
11.55 (2.00%)
Viyash Scientific Ltd.
267.40
7.90 (3.04%)
Sanofi Consumer Healthcare India Ltd.
4213.70
63.70 (1.53%)
Blue Jet Healthcare Ltd.
577.65
-7.95 (1.36%)
Healthcare Global Enterprises Ltd.
696.30
-3.65 (0.52%)
Akums Drugs & Pharmaceuticals FAQs
The Buying Price of Akums Drugs & Pharmaceuticals share is 772.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 41.68. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 3.56. Useful to assess the stock's value relative to its book value.
To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Akums Drugs & Pharmaceuticals is 12160.26 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 783.00 & 409.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
